CDKN2A and cancer: Therefore, it is not surprising that both deletion of the entire the INK4B-ARF-INK4A locus and inactivation of each single gene due to mutations or aberrant epigenetic modifications are recurrent across tumors and cancer-cell lines [68,69,70].